Cover Image

Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results

Abstract Background Methotrexate (MTX), commonly used in juvenile idiopathic arthritis (JIA), frequently has to be discontinued due to intolerance with anticipatory and associative gastrointestinal adverse effects. Eye Movement Desensitization and Reprocessing (EMDR) is a psychological method where...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lea Höfel (Author), Bruno Eppler (Author), Magdalena Storf (Author), Elizabeth Schnöbel-Müller (Author), Johannes-Peter Haas (Author), Boris Hügle (Author)
Format:	Book
Published:	BMC, 2018-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Duration of effect in treatment of methotrexate intolerance in juvenile idiopathic arthritis using Eye Movement Desensitization and Reprocessing (EMDR) can be improved by Bi-lateral Alternating Stimulation Tactile (BLAST) wristbands
by: Lea Höfel, et al.
Published: (2024)

Educational Implications: Physiological Changes in Eye Movement Desensitization and Reprocessing Treatment for Post-Traumatic Stress Disorder
by: Jeffery Scott Herman, et al.
Published: (2024)

Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systems
by: Hugle Boris, et al.
Published: (2013)

The Effect of Eye Movement Desensitization and Reprocessing on Patient Anxiety while Waiting Cardiac Catheterization
by: N Abdi, et al.
Published: (2016)

The Effect of Eye Movement Desensitization and Reprocessing on Anxiety and Pain after Appendectomy in Hospitalized Children
by: Afarin Ghanavatpour, et al.
Published: (2023)

The Effect of Eye Movement Desensitization and Reprocessing (EMDR) on Depression in Spinal Cord Injury Patients
by: Mohammad Reza Sheikhi, et al.
Published: (2021)

Aplikasi eye moving desensitization dan reprocessing dalam konseling post-traumatic stress disorder
by: Hengki Satrianta
Published: (2017)

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
by: Rosanne M. Smits, et al.
Published: (2020)

In pediatric rheumatologic disease, methotrexate leads to mildly changed bloodwork on the second day after administration
by: Boris Hugle, et al.
Published: (2022)

Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication
by: Boris Hügle, et al.
Published: (2021)

Successful Treatment of a Veteran Suffering from Post-Traumatic Stress Disorder due to War Using Eye Movement Desensitization and Reprocessing a Case Report
by: M. Behnammoghadam, et al.
Published: (2014)

Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systems
by: Hugle Boris, et al.
Published: (2011)

Prevalence of methotrexate intolerance in juvenile idiopathic arthritis and possible risk factors: a tertiary center experience
by: Zahide Ekici Tekin, et al.
Published: (2022)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
by: Sonja Falvey, et al.
Published: (2017)

POSSIBLE PARENTERAL METHOTREXATE APPLICATION IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Yu. М. Spivakovsky, et al.
Published: (2014)

A Randomized, Controlled Trial of Wholistic Hybrid Derived From Eye Movement Desensitization and Reprocessing and Emotional Freedom Technique (WHEE) for Self-Treatment of Pain, Depression, and Anxiety in Chronic Pain Patients
by: Daniel Benor MD, et al.
Published: (2017)

A Randomized, Controlled Trial of Wholistic Hybrid Derived From Eye Movement Desensitization and Reprocessing and Emotional Freedom Technique (WHEE) for Self-Treatment of Pain, Depression, and Anxiety in Chronic Pain Patients
by: Daniel Benor MD, et al.
Published: (2017)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
by: Ludwig Zeller, et al.
Published: (2022)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
by: Pluijm Saskia M F, et al.
Published: (2011)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012)

Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general population
by: Jenny Schlichtiger, et al.
Published: (2017)

Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients
by: Marie-Therese Holzer, et al.
Published: (2022)

EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012)

Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008)

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
by: Wulffraat NM, et al.
Published: (2011)

Perbedaan Pengaruh Eye Movement Desensitization And Reprocessing (EMDR) Dengan Teknik Stabilisasi Untuk Menurunkan Posttraumatic Stress Disorder (PTSD) PadaPenyandang Tuna Daksa Pasca Mengalami Kecelakaan Lalu Lintas
by: Rahmania, Ananda Rizka
Published: (2012)

Genetic determinants for methotrexate response in juvenile idiopathic arthritis
by: Serena ePastore, et al.
Published: (2015)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF TREATMENT USING ADALIMUMAB IN COMBINATION WITH METHOTREXATE AND METHOTREXATE MONOTHERAPY IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS IN COMBINATION WITH UVEITIS
by: V. А. Kel'tsev, et al.
Published: (2014)

Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning
by: Xiaolan Mo, et al.
Published: (2019)

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis
by: Maarit Tarkiainen, et al.
Published: (2022)

EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012)

Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
by: Novik GA, et al.
Published: (2011)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
by: van Wijk Femke, et al.
Published: (2011)

Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors
by: Estefanía Barral Mena, et al.
Published: (2020)

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
by: Julia E. Möhlmann, et al.
Published: (2024)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
by: Anders Öman, et al.
Published: (2021)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
by: Tzaribachev N, et al.
Published: (2008)

The Efficacy of Combination Therapy by Adalimumab with Methotrexate and of Monotherapy by Methotrexate for Children Suffering from Polyarticular Juvenile Idiopathic Arthritis
by: V. A. Keltsev, et al.
Published: (2016)

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
by: V. A. Kel'tsev, et al.
Published: (2015)